Antonio López-Villegas1, Daniel Catalán-Matamoros2, Carlos Martín-Saborido3, Irene Villegas-Tripiana4, Emilio Robles-Musso5. 1. Division of Medicine, Nordland Hospital, Bodø, Norway; Institute of Clinical Medicine, Faculty of Health Sciences, University of Tromsø, Tromsø, Norway. Electronic address: antoniolopezvillegas@andaluciajunta.es. 2. Departamento de Periodismo y Comunicación, Universidad Carlos III, Madrid, Spain. 3. Unidad de Evaluación de Tecnología Sanitaria, Universidad Francisco de Vitoria, Madrid, Spain. 4. Unidad de Apoyo a la Investigación y Biblioteca, Hospital de Poniente, El Ejido, Almería, Spain. 5. Unidad de Cuidados Intensivos, Hospital de Poniente, El Ejido, Almería, Spain.
Abstract
INTRODUCTION AND OBJECTIVES: Over the last decade, telemedicine applied to pacemaker monitoring has undergone extraordinary growth. It is not known if telemonitoring is more or less efficient than conventional monitoring. The aim of this study was to carry out a systematic review analyzing the available evidence on resource use and health outcomes in both follow-up modalities. METHODS: We searched 11 databases and included studies published up until November 2014. The inclusion criteria were: a) experimental or observational design; b) studies based on complete economic evaluations; c) patients with pacemakers, and d) telemonitoring compared with conventional hospital monitoring. RESULTS: Seven studies met the inclusion criteria, providing information on 2852 patients, with a mean age of 81 years. The main indication for device implantation was atrioventricular block. With telemonitoring, cardiovascular events were detected and treated 2 months earlier than with conventional monitoring, thus reducing length of hospital stay by 34% and reducing routine and emergency hospital visits as well. There were no significant intergroup differences in perceived quality of life or number of adverse events. The cost of telemonitoring was 60% lower than that of conventional hospital monitoring. CONCLUSIONS: Compared with conventional monitoring, cardiovascular events were detected earlier and the number or hospitalizations and hospital visits was reduced with pacemaker telemonitoring. In addition, the costs associated with follow-up were lower with telemonitoring.
INTRODUCTION AND OBJECTIVES: Over the last decade, telemedicine applied to pacemaker monitoring has undergone extraordinary growth. It is not known if telemonitoring is more or less efficient than conventional monitoring. The aim of this study was to carry out a systematic review analyzing the available evidence on resource use and health outcomes in both follow-up modalities. METHODS: We searched 11 databases and included studies published up until November 2014. The inclusion criteria were: a) experimental or observational design; b) studies based on complete economic evaluations; c) patients with pacemakers, and d) telemonitoring compared with conventional hospital monitoring. RESULTS: Seven studies met the inclusion criteria, providing information on 2852 patients, with a mean age of 81 years. The main indication for device implantation was atrioventricular block. With telemonitoring, cardiovascular events were detected and treated 2 months earlier than with conventional monitoring, thus reducing length of hospital stay by 34% and reducing routine and emergency hospital visits as well. There were no significant intergroup differences in perceived quality of life or number of adverse events. The cost of telemonitoring was 60% lower than that of conventional hospital monitoring. CONCLUSIONS: Compared with conventional monitoring, cardiovascular events were detected earlier and the number or hospitalizations and hospital visits was reduced with pacemaker telemonitoring. In addition, the costs associated with follow-up were lower with telemonitoring.
Authors: Remedios López-Liria; Antonio López-Villegas; Terje Enebakk; Hilde Thunhaug; Knut Tore Lappegård; Daniel Catalán-Matamoros Journal: Int J Environ Res Public Health Date: 2019-06-05 Impact factor: 3.390
Authors: Antonio Lopez-Villegas; Daniel Catalan-Matamoros; Salvador Peiro; Knut Tore Lappegard; Remedios Lopez-Liria Journal: PLoS One Date: 2020-01-29 Impact factor: 3.240
Authors: Antonio Lopez-Villegas; César Leal-Costa; Mercedes Perez-Heredia; Irene Villegas-Tripiana; Daniel Catalán-Matamoros Journal: Int J Environ Res Public Health Date: 2021-11-18 Impact factor: 3.390
Authors: Rafael Jesus Bautista-Mesa; Antonio Lopez-Villegas; Salvador Peiro; Daniel Catalan-Matamoros; Emilio Robles-Musso; Remedios Lopez-Liria; Cesar Leal-Costa Journal: BMC Geriatr Date: 2020-11-16 Impact factor: 3.921
Authors: Daniel Catalan-Matamoros; Antonio Lopez-Villegas; Knut Tore Lappegård; Remedios Lopez-Liria Journal: Int J Environ Res Public Health Date: 2020-10-21 Impact factor: 3.390